Thomas R. Beck
Plus aucun poste en cours
Provenance du réseau au premier degré de Thomas R. Beck
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Thomas R. Beck via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Virginia Commonwealth University | College/University | Doctorate Degree | |
| Virginia Polytechnic Institute & State University | College/University | Undergraduate Degree | |
| CURIS, INC. | Biotechnology | General Counsel | |
AlphaVax, Inc.
 AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| University of Puget Sound | College/University | Undergraduate Degree | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TWIST BIOSCIENCE CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
LakePharma, Inc.
 LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 14 |
Sectorielle
| Health Technology | 10 |
| Consumer Services | 4 |
| Finance | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 5 |
| General Counsel | 5 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Aaron Sato | 8 |
| Lynn G. Baird | 7 |
- Bourse
- Insiders
- Thomas R. Beck
- Connexions Sociétés
